The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.
暂无分享,去创建一个
[1] M. Mendelsohn,et al. Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.
[2] D. Reboussin,et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000, The New England journal of medicine.
[3] M. Furman,et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. , 2000, Circulation.
[4] D. Levy,et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[5] D. Grigoryev,et al. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[6] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[7] P. Shaul,et al. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. , 1998, The Journal of clinical investigation.
[8] G. Kajiyama,et al. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[9] P. Bray,et al. PlA2 polymorphism and efficacy of aspirin , 1998, The Lancet.
[10] P. Bray,et al. Gender Differences in Platelet GPIIb-IIIa Activation , 1997, Thrombosis and Haemostasis.
[11] P. Ridker,et al. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis , 1997, The Lancet.
[12] R. Fox,et al. Refining the treatment of women with unstable angina—A randomized, double‐blind, comparative safety and efficacy evaluation of integrelin™ versus aspirin in the management of unstable angina , 1996 .
[13] J. Weiss,et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. , 1996, The New England journal of medicine.
[14] K. Blakemore,et al. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations , 1995, Transfusion.
[15] A. Nurden. Polymorphisms of Human Platelet Membrane Glycoproteins: Structure and Clinical Significance , 1995, Thrombosis and Haemostasis.
[16] E. Barrett-Connor,et al. Estrogen and coronary heart disease in women , 1991, JAMA.
[17] R. Aster,et al. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. , 1989, The Journal of clinical investigation.